Deep Tech Startups

Fortemedia develops embedded voice processing software that suppresses background noise and enhances speech clarity for Windows-based devices, primarily laptops and tablets. The company uses microphone array processing and deep learning to deliver voice communications and acoustic control features even in noisy environments.

2 investors

Fortytwo operates a sovereign, participant-owned AI network that uses swarm inference to combine heterogeneous AI models into a single networked intelligence. The platform delivers frontier-grade performance for applications requiring high accuracy and operates on consumer-grade hardware through a node-runner reward system.

2 investors

Fourier Optics builds Fourier AR, an angular and wavelength-selective metasurface optical combiner embedded invisibly inside ophthalmic lenses that reflects RGB light from a µLED projector to the eye for all-day augmented-reality glasses. The technology is designed for OEMs and lens manufacturers using standard semiconductor fabrication and ophthalmic lens workflows, supporting prescription vision correction.

2 investors

Fovionics develops smart glasses for blind and visually impaired people, aimed at assisting with reading and daily tasks. The company focuses on making assistive vision technology affordable, with roots addressing accessibility gaps in Brazil.

2 investors

Frankenburg Technologies develops affordable, mass-manufacturable guided missile systems and counter-drone platforms for European defence. The company builds air and missile defence solutions for rapid replenishment and sustained industrial-scale operations.

2 investors

Fraunhofer is a research organization whose Institute for Toxicology and Experimental Medicine (ITEM) conducts contract research, including cell-based in vitro inhalation methods to assess respiratory effects of aerosols and identify potentially harmful substances without animal testing. Its work supports safe product development under a safe-by-design approach.

2 investors

Fraym produces census-like, ward-level population data anywhere in the world using novel data sources and AI. The company offers a geospatial population data platform, including publicly available insights on women's agency across communities.

2 investors

Fulcrum Autonomy develops autonomy and related capabilities aimed at tactical and strategic advantage for defense and national security customers.

2 investors

Fundamental.ai develops large language models built from first principles, with each component designed around explicit mathematical understanding rather than opaque emergent behavior. The company positions its approach as an alternative to conventional LLM training, aiming for more interpretable and predictable AI.

2 investors

Fusion Energy Partners provides engineering and technical consulting services to fusion energy research projects and organizations, drawing on deep expertise in fusion system design, construction, operation, and decommissioning.

2 investors

FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.

2 investors

Futurail develops a safety-certified autonomy software and hardware stack for self-driving trains, including long-range obstacle detection, localization, and train control, offered as first-mount integration with OEMs or retrofits of existing fleets. It serves freight and passenger rail operators and vehicle manufacturers, and is based in Strasbourg and Munich.

2 investors

Gain Therapeutics is a biotechnology company that develops small molecule drugs targeting allosteric binding sites on disease-related proteins, using its computational Magellan platform to discover compounds that stabilize or destabilize proteins to treat central nervous system disorders, lysosomal storage diseases, metabolic disorders, and oncology; its lead candidate GT-02287 is in Phase 1b testing for Parkinson's disease.

2 investors

Galam Robotics develops modular warehouse automation robots that integrate into existing fulfillment operations, enabling higher throughput, vertical storage utilization, and flexible order routing without requiring facility redesign. The solution serves e-commerce and logistics companies seeking to increase capacity and operational efficiency.

2 investors

Galaxea AI provides a platform for developing embodied AI systems, offering data collection, quality assurance, model post-training, and deployment tools for robotics developers. The platform integrates open-source embodied AI models and proprietary models (G0, G0.5 series) with one-click fine-tuning capabilities.

2 investors

Isolation Bio (Galt Inc.) develops the Prospector Discovery Platform, a high-throughput, automated microbial cultivation array technology that isolates, cultivates, and screens thousands of microbes in parallel. It also offers a microbial isolation and cultivation service for researchers working on microbiome applications in human health, animal health, crop improvement, and environmental health.

2 investors

GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.

2 investors

Gattaca builds and operates high-performance blockchain infrastructure that delivers blockspace, handling transaction routing, block construction, and delivery across the on-chain supply chain. Founded in 2018 as a trading firm before pivoting to infrastructure, it serves major public blockchain networks.

2 investors

GattaCo develops a blood plasma separator device that enables point-of-care collection and transport of lab-quality plasma for remote blood testing and monitoring. The A-PON Plasma Separator uses passive elution technology to extract plasma from finger-stick blood samples for later laboratory analysis.

2 investors

Gazelle Wind Power develops a floating platform system for offshore wind turbines designed to reduce weight, mooring complexity, and operational costs compared to conventional solutions. The platform uses an innovative mooring design that minimizes platform pitch and maintenance requirements while enabling deployment in deeper waters.

2 investors

Gear Technologies develops blockchain infrastructure, including the Vara Network and Vara.ETH, along with the Gear Foundation. It focuses on smart-contract and decentralized application technology within the crypto/Web3 space.

2 investors

Gega Elements is a materials science company developing gallium refining technology based on proprietary research, aiming for a cost-effective and sovereign-controlled processing pathway. It is collaborating with RareX to test gallium-bearing samples and build a vertically integrated gallium supply chain in Western Australia.

2 investors

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

2 investors

General Reasoning (GR) is an AI research company that trains models to work, communicate, and coordinate over long time horizons, with a focus on reinforcement learning, multi-agent systems, and environment design. It also publishes open releases such as benchmarks and RL environment tools to support the wider research community.

2 investors